Lupin Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LUPIN.NS | IPCALAB.BO | MOREPENLAB.NS | IOLCP.NS | FREDUN.BO | 000230.KS | |
|---|---|---|---|---|---|---|
| Market cap | 909.09B | 494.67B | 53.21B | 55.50B | 25.51B | 65.20B |
| P/E (TTM) | 17.5 | 37.8 | 28.3 | 27.3 | 54.2 | — |
| Forward P/E | 19.6 | 27.7 | — | 17.5 | — | — |
| Price/book | 3.8 | 6.1 | 3.9 | 2.9 | 8.8 | — |
| Dividend yield | 0.90% | 0.30% | 0.20% | 0.54% | 0.02% | 1.79% |
| 1-year change | +2.72% | +51.51% | +113.46% | +102.86% | +192.50% | −52.38% |
| Today | −1.03% | −1.18% | −4.17% | +2.89% | −1.07% | +0.89% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All LUPIN.NS news ›Lupin Expects Reduced Operating Margins In FY28 Following Executive Management Interview
Lupin faces medium-term margin pressure due to key US product price erosion, despite maintaining its FY27 margin outlook of 24%–25%. The company is stepping up investment in pipeline assets like Apixaban to prepare for new product…
Lupin Q2 net profit falls 22.19 pc to Rs 1,155.3 cr
New Delhi, Nov 4 (PTI) Homegrown pharma major Lupin on Wednesday posted a 22.19 per cent decline in consolidated net profit to Rs 1,155.30 crore in the September quarter, dragged by an exceptional item and a drop in operating income. The…
More from 1 other outlet
Q2 Results 04th Nov Live: BSE, Cummins, Zydus Lifesciences, Apollo, Lenskart, Nykaa, Aurobindo Pharma, NHPC, Dabur, Torrent Power, Biocon, Sundaram Finance, Premier Energies, Physicswallah Share to announce Q2 results, Bajaj Finserv, SBI, NSE, Lupin shares in focus
Follow our stock market live updates here | Stay tuned to businessline for more. GAINERS: SBI, Emcure Pharma, Awfis Space Sensex gained 214.75 pts or 0.28% to 77,132.60 at 9.16 am after opening at 76,853.11 from 76,917.85 previous close.…
Lupin Limited names Akhil Gupta as Independent Director to its board
Pharma major, Lupin Limited has appointed Akhil Gupta as an Independent Director to its Board. Pharma major, Lupin Limited has appointed Akhil Gupta as an Independent Director to its Board. Gupta, who was associated with the Bharti…
More from 1 other outlet
Lupin Q2 FY27 Results Reveal A Mixed Earnings Picture, Net Profit Declines 22% To ₹1,155 Crore Even As Sales Register A Healthy 14% Growth
Mumbai: Pharmaceutical major Lupin Limited reported a 22.2 per cent year-on-year decline in consolidated profit after tax (PAT) to ₹1,155.3 crore for the quarter ended September 30, 2026 (Q2 FY27), compared with ₹1,484.8 crore in the…
Seiko Reveals New Official Lupin III Watch Inspired by Daisuke Jigen
Seiko has revealed a new official Lupin III collaboration watch inspired by Daisuke Jigen and some of the expert gunman’s most famous details. The “Lupin III Chronograph Daisuke Jigen Model” is a Seiko-made chronograph released through…
Lupin Limited Board approves Q2 FY27 unaudited financial results
Lupin Limited announced that its Board of Directors has unanimously approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. The results, along with the limited review…
Lupin Part 4 Hits No. 1 in 46 Countries on Netflix but Misses the US Top 10
That gap matters because the season did not peak on arrival. It grew. Viewing rose in the second week, the list of countries where it sits at the top roughly doubled, and the three older parts climbed back into the global chart alongside…
Lupin reports Q2 FY27 results with ₹77,855 million in net sales
Lupin Limited announces Q2 FY27 financial results: Net Sales ₹77,855 million (14% YoY growth), EBITDA ₹19,574 million, and Net Income ₹11,553 million. Includes regional performance and key developments. Lupin reports Q2 FY27 results with…
More from 1 other outlet
Lupin reports Q2 FY2027 sales of INR 77,855 Mn, a 14% year-on-year increase
Pharmaceutical giant Lupin Limited has announced its financial results for the second quarter ending 30 September 2026. The company's sales during the quarter reached INR 77,855 Mn, representing a 14% increase from INR 68,314 Mn in the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- moneycontrol.com6
- thehindubusinessline.com6
- businessupturn.com3
- scanx.trade3
- biotecnika.org2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 43 articles, not a forecast.